GGrantIndex
← Leaderboards

John W Park

University Of California San Francisco

$3,200,648
Attributed
$3,200,648
Total exposure
5
Grants
4
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $438.5K · FY200512
$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12

Funding mix

By agency

NIH$3,200,648 · 5

By mechanism

P50$2,804,634 · 3
U54$316,544 · 1
R03$79,470 · 1

Top collaborators

No co-investigators on record.

Most similar at University Of California San Francisco

Same institution · by research overlap

Others in their field

Top investigators on “Clinical Trials

Research focus

Clinical TrialsTissuesMalignant NeoplasmsCollaborationsDrug Delivery SystemsMalignant Breast NeoplasmProgramsDoxorubicinLiposomesReceptorTranslationsResponseSeriesLeadLinkGene ExpressionTissue /Cell CultureMonoclonal AntibodyAntibodiesCancer CellCancer Cell LineAnthracyclinesBacteriophagesAdvocate

Grant awards (20)

Lipidic Nanoparticle Drugs against Agressive Breast Cancer Subtypes$327,264
P50 · FY2012 · CA · contact PI
Advocacy Core$111,252
P50 · FY2012 · CA · contact PI
Lipidic Nanoparticle Drugs against Agressive Breast Cancer Subtypes$263,974
P50 · FY2011 · CA · contact PI
Advocacy Core$89,843
P50 · FY2011 · CA · contact PI
Lipidic Nanoparticle Drugs against Agressive Breast Cancer Subtypes$320,140
P50 · FY2010 · CA · contact PI
Advocacy Core$108,162
P50 · FY2010 · CA · contact PI
Lipidic Nanoparticle Drugs against Agressive Breast Cancer Subtypes$304,459
P50 · FY2009 · CA · contact PI
Advocacy Core$102,094
P50 · FY2009 · CA · contact PI
Lipidic Nanoparticle Drugs against Agressive Breast Cancer Subtypes$213,344
P50 · FY2008 · CA · contact PI
Advocacy Core$71,458
P50 · FY2008 · CA · contact PI
Development of novel therapeutics for brain tumor$188,006
P50 · FY2006 · CA · contact PI
CHARACTERIZATION AND PROFILING OF MICROMETASTASES$158,272
U54 · FY2006 · CA · contact PI
Development of novel therapeutics for brain tumor$183,165
P50 · FY2005 · CA
Development of novel therapeutics for brain tumor$178,464
P50 · FY2004 · CA
Development of novel therapeutics for brain tumor$173,901
P50 · FY2003 · CA
Development of novel therapeutics for brain tumor$169,108
P50 · FY2002 · CA
CHARACTERIZATION AND PROFILING OF MICROMETASTASES$158,272
U54 · FY2002 · CA
ANTIERBB2 ANTIBODY INDUCED PROTEIN INTERACTIONS$39,800
R03 · FY2001 · TW
CHARACTERIZATION AND PROFILING OF MICROMETASTASES$0
U54 · FY2001 · CA
ANTIERBB2 ANTIBODY INDUCED PROTEIN INTERACTIONS$39,670
R03 · FY2000 · TW